What is Xylem's payments for repurchase of common stock?

Xylem (XYL) reported payments for repurchase of common stock of $680M in Q2 2026.

What is the long-term trend for Xylem's payments for repurchase of common stock?

Over 2 years (2023 to 2025), Xylem's payments for repurchase of common stock has grown at a -22.5% compound annual growth rate (CAGR), from $25M to $15M.

Xylem XYL Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

MGP IngredientsMGPI

$886K-14.4%

Torrid HoldingsCURV

$186K—

Frequency ElectronicsFEIM

$0—

Trustco Bank CorpTRST

$23.91M—

FTI ConsultingFCN

$126.83M-30.6%

Healthcare Services GroupHCSG

$20.93M+173%

Other financials

Income statement

See full

Revenue$2.3B+1.5%

Gross profit$963.0M+8.0%

Operating income$390.0M+27.9%

Net income$263.0M+16.4%

EPS (diluted)$1.11+19.4%

Balance sheet

See full

Cash & equivalents$1.3B+9.1%

Total debt$3.6B+63.6%

Total equity$10.4B-5.9%

Total assets$17.3B+0.9%

Cash flow

See full

Operating cash flow$290.0M-4.9%

CapEx$89.0M-9.2%

Free cash flow$201.0M-2.9%

Valuation

See full

Market cap$28.56B-11.3%

Enterprise value$30.87B-7.0%

P/E28.1×-6.3×

P/S3.1×-0.6×

Profitability

See full

Gross margin39.2%+1.4pp

Operating margin14.5%+2.1pp

Net margin11.2%+0.4pp

FCF margin10.5%+0.4pp

Returns & leverage

See full

Return on equity9.5%+0.7pp

Debt / equity0.3×+0.1×

Current ratio1.6×-0.3×

Where this comes from

Reported directly by Xylem in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Xylem’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xylem's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xylem's payments for repurchase of common stock?: Xylem (XYL) reported payments for repurchase of common stock of $680M in Q2 2026.
What is the long-term trend for Xylem's payments for repurchase of common stock?: Over 2 years (2023 to 2025), Xylem's payments for repurchase of common stock has grown at a -22.5% compound annual growth rate (CAGR), from $25M to $15M.